The novel coronavirus is a severe infectious problem caused by SARS-coV-2. It was first started in Wuhan community belonging to China and spread as a pandemic. Coronavirus mainly spreads through contact with respiratory droplets. Symptoms include fever, shortness of breath, body pains, cough, and chest pain. The main objectives of this study are to evaluate the comorbidities and severity in patients with covid-19, to compare the mortality between males and females, and to determine the association between sex and age and significant clinical symptoms during the study period. The methodology includes reviewing the case sheets in the medical record room and preparing the structural data form relevant to the aim and objectives of the study. A total of 96 cases were identified and resolved. Out of those age groups, 48-58 are majorly affected by covid-19, especially males. Hypertension triggers the most i.e.,23%. Patients with dry cough have more impact on covid-19 than other clinical manifestations. Our study concludes that individuals between 48-58 years are at high risk of developing coronavirus. Hypertension triggers a significant impact on SARS-coV-2 compared to other comorbidities.

REFERENCES

1.          Zehra Z, Luthra M, Siddiqui SM, Shamsi A, Gaur NA, Islam A. Corona virus versus existence of human on the earth: A computational and biophysical approach. Int J Biol Macromol. 2020;161:271-81. doi: 10.1016/j.ijbiomac.2020.06.007, PMID 32512089.

2.          Hafeez A, Ahmad S, Siddqui SA, Ahmad M, Mishra S. A review of covid-19 (coronavirus disease-2019) diagnosis, treatments and preventions. Eurasian J Med Oncol. 2020;4(2):116-25.

3.          Taleghani N, Taghipour F. Diagnosis of covid-19 for controlling the pandemic: a review of the state-of-the-art. Biosens Bioelectron. 2021;174:112830. doi: 10.1016/j.bios.2020.112830, PMID 33339696.

4.          Upadhyay J, Tiwari N, Ansari MN. Role of inflammatory markers in corona virus disease (covid-19) patients: a review. Exp Biol Med (Maywood). 2020;245(15):1368-75. doi: 10.1177/1535370220939477, PMID 32635752.

5.          Wadood N, Toro AU, Madan A. A review on covid-19: the Epidemiology, Transmission, Impact on Pregnancy and Reproductive Health and Its Prevention. J Womens Health Care;10(2):1-5.

6.          Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE et al. COVID-19 and comorbidities: deleterious impact on infected patients. J Infect Public Health. 2020;13(12):1833-9. doi: 10.1016/j.jiph.2020.07.014, PMID 32788073.

7.          Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging. 2020;12(7):6049-57. doi: 10.18632/aging.103000, PMID Pubmed.

8.          Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N et al. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis. J Med Virol. 2020;92(10):1915-21. doi: 10.1002/jmv.25889, PMID 32293753.

9.          Gold MS, Sehayek D, Gabrielli S, Zhang X, McCusker C, Ben-Shoshan M. COVID-19 and comorbidities: a systematic review and meta-analysis. Postgrad Med. 2020;132(8):749-55. doi: 10.1080/00325481.2020.1786964, PMID 32573311.

10.        Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Intervirology. 2020:1-12. doi: 10.1159/000512592. PMID 33296901.

11.        Bonanad C, García-Blas S, Tarazona-Santabalbina F, Sanchis J, Bertomeu-González V, Fácila L et al. The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects. J Am Med Dir Assoc. 2020;21(7):915-18. doi: 10.1016/j.jamda.2020.05.045, PMID 32674819.

12.        Biccard BM, Gopalan PD, Miller M, Michell WL, Thomson D, Ademuyiwa A et al. Patient care and clinical outcomes for patients with covid-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study. The Lancet. 2021;397(10288):1885-94. doi: 10.1016/S0140-6736(21)00441-4.

13.        Tan E et al. Global impact of coronavirus disease 2019 infection requiring admission to the ICU: A systemic review and meta-analysis; PubMed. 2021;159(2):524-36.

14.        Starke KR. Gabriela petereist-Haack and Adreas Seidler et al., The age-related risk of severe outcomes due to covid-19 infection: A rapid review, meta-analysis and meta-regression. Int J Environ Res Public Health. 2021;17(16):5974.

15.        Ruchong Chen MD, Liang W, et al. Risk factors of fatal outcomes in hospitalized subjects with coronavirus disease 2019 from a national wide analysis in China; Chest Infections [journal]. 2020;158(1):97-105.